Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.27 CAD | -6.90% | +8.00% | +42.11% |
May. 17 | Aeterna Zentaris Finalizes Some Details for Ceapro Merger | MT |
May. 17 | Aeterna and Ceapro Brief: Aeterna Zentaris Announcing Details Regarding Transaction with Ceapro | MT |
Business Summary
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Active Ingredient Product Technology
100.0
%
| 19 | 100.0 % | 10 | 100.0 % | -48.87% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Germany
49.9
%
| 6 | 31.5 % | 5 | 49.9 % | -19.00% |
United States
47.8
%
| 11 | 58.8 % | 5 | 47.8 % | -58.41% |
Other
1.8
%
| 0 | 0.4 % | 0 | 1.8 % | +153.54% |
Canada
0.3
%
| 0 | 0.2 % | 0 | 0.3 % | -15.21% |
China
0.1
%
| 2 | 9.2 % | 0 | 0.1 % | -99.38% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gilles Gagnon
CEO | Chief Executive Officer | 70 | 06-12-31 |
Director of Finance/CFO | - | 15-05-04 | |
Mitch Regnier
CTO | Chief Tech/Sci/R&D Officer | - | 23-04-30 |
Paul Moquin
CTO | Chief Tech/Sci/R&D Officer | - | 18-01-31 |
Chief Tech/Sci/R&D Officer | - | 09-12-31 | |
General Counsel | - | - | |
Leoni DeJoya
PRN | Corporate Officer/Principal | - | 19-01-06 |
52 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gilles Gagnon
CEO | Chief Executive Officer | 70 | 06-12-31 |
Ulrich Kosciessa
BRD | Director/Board Member | - | 15-04-26 |
William Li
BRD | Director/Board Member | 61 | 14-11-19 |
Ronald Miller
CHM | Chairman | - | 22-03-01 |
Geneviève Foster
BRD | Director/Board Member | - | 22-04-18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 78,293,177 | 75,156,073 ( 95.99 %) | 0 | 95.99 % |
Company contact information
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+42.11% | 15.53M | |
+41.79% | 54.04B | |
+46.23% | 41.96B | |
-0.56% | 41.92B | |
-7.20% | 28.35B | |
+12.59% | 26.35B | |
-21.51% | 19B | |
+6.92% | 13B | |
+29.60% | 12.28B | |
+24.91% | 12.19B |
- Stock Market
- Equities
- CZO Stock
- Company Ceapro Inc.